World Equity Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,398
Closed -$202K – 338
2022
Q1
$202K Buy
+4,398
New +$210K 0.04% 343

Other funds holding ARKG

World Equity Group's ARKG Position: Q2 2022 in Review

World Equity Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,398 shares — an estimated $202K sold.

World Equity Group first reported a position in ARKG in Q1 2022 and held it in 1 quarter. The position peaked at $202K in Q1 2022. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • World Equity Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • World Equity Group sold 4,398 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $202K.
  • World Equity Group first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 1 quarter.
  • World Equity Group's ARK Genomic Revolution ETF position peaked at $202K in Q1 2022.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on World Equity Group's 13F filing for Q2 2022, filed 6 Sep 2024.